True Leaf Expands Global Retail Presence
05 nov. 2018 07h00 HE
|
True Leaf Medicine International Ltd.
Now in 2,800 stores worldwide, True Leaf is also reaching more customers online with the launch of direct-to-consumer stores in France, Germany, and the UK VERNON, British Columbia, Nov. 05, 2018 ...
Sovrin Foundation Welcomes TwinPeek as Founding Steward
24 oct. 2018 12h49 HE
|
Sovrin.org
PROVO, UTAH and GRENOBLE, FRANCE, Oct. 24, 2018 (GLOBE NEWSWIRE) -- The Sovrin Foundation, an international nonprofit that administers a decentralized digital identity network, welcomes TwinPeek as...
HEXO Corp. se mondialise et implante des sites de production en Grèce pour distribuer ses marques en Europe
26 sept. 2018 06h30 HE
|
HEXO Corp.
GATINEAU, Québec, 26 sept. 2018 (GLOBE NEWSWIRE) -- HEXO Corp. (« HEXO » ou la « Société ») (TSX: HEXO) planifie la création en Grèce d’un centre de transformation, de production et de...
HEXO Corp. goes global, establishes Greek manufacturing facilities for distribution throughout Europe, including France and the UK
26 sept. 2018 06h30 HE
|
HEXO Corp.
GATINEAU, Quebec, Sept. 26, 2018 (GLOBE NEWSWIRE) -- HEXO Corp. (“HEXO” or the “Company”) (TSX:HEXO) plans to establish a Eurozone processing, production and distribution centre in Greece. The...
ERYTECH annonce le recrutement des premiers patients dans son étude clinique de Phase 3 avec eryaspase pour le traitement en seconde ligne du cancer du pancréas
20 sept. 2018 01h30 HE
|
Erytech Pharma S.A.
LYON, France et CAMBRIDGE, Mass., 20 sept. 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), société biopharmaceutique de stade clinique qui développe des thérapies...
ERYTECH Announces Enrollment of First Patients in Phase 3 Clinical Trial Evaluating Eryaspase for the Treatment of Second Line Pancreatic Cancer
20 sept. 2018 01h30 HE
|
Erytech Pharma S.A.
LYON, France and CAMBRIDGE, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies...
ERYTECH partecipa alle prossime conferenze degli investitori
13 sept. 2018 17h30 HE
|
Erytech Pharma S.A.
LIONE, Francia, Sept. 13, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), una società biofarmaceutica di fase clinica che sviluppa terapie innovative incapsulando...
ERYTECH nimmt an kommenden Investorenkonferenzen teil
13 sept. 2018 17h30 HE
|
Erytech Pharma S.A.
LYON, Frankreich, Sept. 13, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), ein in der klinischen Entwicklungsphase tätiges Biopharma-Unternehmen, das innovative...
ERYTECH participera à plusieurs conférences d'investisseurs
13 sept. 2018 01h30 HE
|
Erytech Pharma S.A.
LYON, France, 13 sept. 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext : ERYP – Nasdaq : ERYP), société biopharmaceutique de stade clinique qui développe des thérapies innovantes en encapsulant...
ERYTECH to Attend Upcoming Investor Conferences
13 sept. 2018 01h30 HE
|
Erytech Pharma S.A.
LYON, France, Sept. 13, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating...